{"title": "medical-policy-category-view", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2021-02-09", "cleaned_text": "| |[621](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/621A%20Quality%20Care%20Dosing%20Guidelines%20prn.pdf) | |[A Quality Care Dosing Guidelines](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/621A%20Quality%20Care%20Dosing%20Guidelines%20prn.pdf) | |[719](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/719%20Ablation%20Procedures%20for%20Peripheral%20Neuromas%20prn.pdf) Peripheral Neuromas](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/719%20Ablation%20Procedures%20for%20Peripheral%20Neuromas%20prn.pdf) |[186](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/186%20Absorbable%20Nasal%20Implant%20for%20Treatment%20of%20Nasal%20Valve%20Collapse%20prn.pdf) | |[Absorbable Nasal Implant for Valve Collapse](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/186%20Absorbable%20Nasal%20Implant%20for%20Treatment%20of%20Nasal%20Valve%20Collapse%20prn.pdf) | |[111](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/111%20Autografts%20and%20Allografts%20in%20the%20Treatment%20of%20Focal%20Articular%20Cartilage%20Lesions%20prn.pdf) | |[Absorbable Nasal Implant | |[533](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/533%20Actigraphy%20prn.pdf) | |[Actigraphy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/533%20Actigraphy%20prn.pdf) | |[841](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/841%20Adjunctive%20Techniques%20for%20Screening%20and%20Surveillance%20of%20Barrett%20Esophagus%20and%20Esophageal%20Dysplasia.pdf) | |[Adjunctive Techniques for Screening and Surveillance of Barrett Esophagus and Esophageal Dysplasia](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/841%20Adjunctive%20Techniques%20for%20Screening%20and%20Surveillance%20of%20Barrett%20Esophagus%20and%20Esophageal%20Dysplasia.pdf) | |[455](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/455%20Adoptive%20Immunotherapy%20prn.pdf) | |[Adoptive |[Advanced Imaging of the Heart](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/972%20Advanced%20Imaging%20of%20the%20Heart%20prn.pdf) | |[971](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/971%20Advanced%20Imaging%20of%20the%20Heart%20CPT%20and%20HCPCS%20Codes%20prn.pdf) | |[Advanced Imaging of the Heart | |[190](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/190%20Allogeneic%20Hematopoietic%20Cell%20Transplantation%20for%20Genetic%20Diseases%20and%20Acquired%20Anemias%20prn.pdf) | |[Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/190%20Allogeneic%20Hematopoietic%20Cell%20Transplantation%20for%20Genetic%20Diseases%20and%20Acquired%20Anemias%20prn.pdf) | |[155](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/155%20Allogeneic%20Hematopoietic%20Cell%20transplantation%20for%20Myelodysplastic%20Syndromes%20and%20Myeloproliferative%20Neoplasms%20prn.pdf) | |[Allogeneic Hematopoietic Injection for Degenerative Disc Disease](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/838%20Allograft%20Injection%20for%20Degenerative%20Disc%20Disease.pdf) | |[347](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/347%20Ambulatory%20Event%20Monitors%20and%20Mobile%20Outpatient%20Cardiac%20Telemetry%20prn.pdf) | |[Ambulatory Event Monitors and Mobile Outpatient Cardiac Telemetry](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/347%20Ambulatory%20Event%20Monitors%20and%20Mobile%20Outpatient%20Cardiac%20Telemetry%20prn.pdf) | |[643](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/643%20Amniotic%20Membrane%20and%20Amniotic%20Fluid%20prn.pdf) | |[Amniotic Membrane |[557](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/557%20Analysis%20of%20Human%20DNA%20in%20Stool%20Samples%20as%20a%20Technique%20for%20Colorectal%20Cancer%20Screening%20prn.pdf) | |[Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/557%20Analysis%20of%20Human%20DNA%20in%20Stool%20Samples%20as%20a%20Technique%20for%20Colorectal%20Cancer%20Screening%20prn.pdf) | |[536](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/536%20Analysis%20of%20Proteomic%20Patterns%20for%20Early%20Detection%20of%20Cancer%20prn.pdf) | |[Analysis of Proteomic Patterns Early of | |[091](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/091%20Applied%20Behavioral%20Analysis%20%28ABA%29.pdf) |[Applied Analysis Technologies (Infertility Services)](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/086%20Assisted%20Reproductive%20Services%20Infertility%20Services%20prn.pdf) | |[011](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/011%20Asthma%20and%20Chronic%20Obstructive%20Pulmonary%20Disease%20Medication%20Management%20prn.pdf) | |[Asthma and Chronic Obstructive Pulmonary Disease Medication Management](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/011%20Asthma%20and%20Chronic%20Obstructive%20Pulmonary%20Disease%20Medication%20Management%20prn.pdf) Cartilage Lesions](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/374%20Autologous%20Chondrocyte%20Implantation%20for%20Focal%20Articular%20Cartilage%20Lesions%20prn.pdf) | |[206](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/206%20Automated%20Ambulatory%20Blood%20Pressure%20Monitoring%20for%20the%20Diagnosis%20of%20Hypertension%20in%20Patients%20with%20Elevated%20Office%20Blood%20Pressure%20prn.pdf) | |[Automated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/206%20Automated%20Ambulatory%20Blood%20Pressure%20Monitoring%20for%20the%20Diagnosis%20of%20Hypertension%20in%20Patients%20with%20Elevated%20Office%20Blood%20Pressure%20prn.pdf) | |[231](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/231%20Automated%20Percutaneous%20and%20Percutaneous%20Discectomy%20prn.pdf) | |[Automated Percutaneous | of Breast Cancer-Related Lymphedema](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/184%20Axillary%20Reverse%20Mapping%20for%20Prevention%20of%20Breast%20Cancer-Related%20Lymphedema.pdf) | |[621](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/621B%20Quality%20Care%20Dosing%20Guidelines%20Drug%20List%20prn.pdf) | |[B Quality | Skin and Soft Tissue Substitutes](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/663%20Bioengineered%20Skin%20and%20Soft%20Tissue%20Substitutes%20prn.pdf) | |[210](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/210%20Biofeedback%20as%20a%20Treatment%20of%20Chronic%20Pain%20prn.pdf) | |[Biofeedback as a Treatment of Chronic Pain](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/210%20Biofeedback%20as%20a%20Treatment%20of%20Chronic%20Pain%20prn.pdf) | |[308](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/308%20Biofeedback%20as%20a%20Treatment%20of%20Fecal%20Incontinence%20or%20Constipation%20prn.pdf) | |[Biofeedback as a Treatment of Fecal Incontinence or Constipation](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/308%20Biofeedback%20as%20a%20Treatment%20of%20Fecal%20Incontinence%20or%20Constipation%20prn.pdf) | |[173](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/173%20Biofeedback%20as%20a%20Treatment%20of%20Urinary%20Incontinence%20prn.pdf) | |[Biofeedback as a Treatment Urinary | | |[Biofeedback for Miscellaneous Indications](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/187%20Biofeedback%20for%20Miscellaneous%20Indications%20prn.pdf) | | |[Biofeedback for the Treatment of Headache](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/152%20Biofeedback%20for%20the%20Treatment%20of%20Headache%20prn.pdf) | |[261](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/261%20Bioimpedance%20Devices%20for%20the%20Detection%20of%20Lymphedema%20prn.pdf) | |[Bioimpedance Devices for the Detection of Lymphedema](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/261%20Bioimpedance%20Devices%20for%20the%20Detection%20of%20Lymphedema%20prn.pdf) | |[336](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/336%20Biomarkers%20for%20Diagnosis%20%26%20Cancer%20Risk%20Assessment%20of%20Prostate%20Cancer%20prn.pdf) | |[Biomarkers for Diagnosis & Cancer Risk Assessment of Prostate Cancer](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/336%20Biomarkers%20for%20Diagnosis%20%26%20Cancer%20Risk%20Assessment%20of%20Prostate%20Cancer%20prn.pdf) | |[058](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/058%20Bisphosphonates%2C%20Oral%20prn.pdf) | |[Bisphosphonates, Oral](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/058%20Bisphosphonates%2C%20Oral%20prn.pdf) | |[101](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/101%20Biventricular%20Pacemakers%20-%20Cardiac%20Resynchronization%20Therapy%20for%20the%20Treatment%20of%20Heart%20Failure%20prn.pdf) | |[Biventricular Pacemakers - Cardiac Resynchronization Therapy for the Treatment of Heart Failure](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/101%20Biventricular%20Pacemakers%20-%20Cardiac%20Resynchronization%20Therapy%20for%20the%20Treatment%20of%20Heart%20Failure%20prn.pdf) | |[740](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/740%20Blepharoplasty%20Blepharoptosis%20repair%20and%20Brow%20ptosis%20repair%20prn.pdf) | |[Blepharoplasty Blepharoptosis repair Morphogenetic Protein](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/097%20Bone%20Morphogenetic%20Protein%20prn.pdf) | |[549](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/549%20Bone%20Turnover%20Markers%20for%20Diagnosis%20and%20Management%20of%20Osteoporosis%20and%20Diseases%20Associated%20with%20High%20Bone%20Turnover%20prn.pdf) | |[Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/549%20Bone%20Turnover%20Markers%20for%20Diagnosis%20and%20Management%20of%20Osteoporosis%20and%20Diseases%20Associated%20with%20High%20Bone%20Turnover%20prn.pdf) | |[006](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/006%20Botulinum%20Toxin%20Injections%20SP%20prn.pdf) | |[Botulinum |[287](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/287%20Cardiac%20Hemodynamic%20Monitoring%20for%20the%20Management%20of%20Heart%20Failure%20in%20the%20Outpatient%20Setting%20prn.pdf) | |[Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/287%20Cardiac%20Hemodynamic%20Monitoring%20for%20the%20Management%20of%20Heart%20Failure%20in%20the%20Outpatient%20Setting%20prn.pdf) | |[916](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/916%20Cardiac%20Rehabilitation%20in%20the%20Outpatient%20Setting%20prn.pdf) | |[Cardiac Rehabilitation in the Outpatient Setting](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/916%20Cardiac%20Rehabilitation%20in%20the%20Outpatient%20Setting%20prn.pdf) |[664](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/664%20Cardiovascular%20Risk%20Panels%20prn.pdf) | |[Cardiovascular Risk Panels](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/664%20Cardiovascular%20Risk%20Panels%20prn.pdf) | |[930](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/930%20Carelon%20Abdomen%20and%20Pelvic%20Imaging%20CPT%20and%20Diagnoses%20Codes%20prn.pdf) | |[Carelon Abdomen and Pelvic Imaging CPT and Diagnoses Codes prn](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/930%20Carelon%20Abdomen%20and%20Pelvic%20Imaging%20CPT%20and%20Diagnoses%20Codes%20prn.pdf) | |[900](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/900%20Carelon%20Advanced%20Imaging%20Radiology%20CPT%20and%20HCPCS%20Codes%20prn.pdf) | |[Carelon | | CPT and Diagnoses Codes prn](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/931%20Carelon%20Brain%20Imaging%20CPT%20and%20Diagnoses%20Codes%20prn.pdf) | |[932](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/932%20Carelon%20Chest%20Imaging%20CPT%20and%20Diagnoses%20Codes%20prn.pdf) | |[Carelon Chest Imaging CPT and prn](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/932%20Carelon%20Chest%20Imaging%20CPT%20and%20Diagnoses%20Codes%20prn.pdf) | |[933](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/933%20Carelon%20Extremity%20Imaging%20CPT%20and%20Diagnoses%20Codes%20prn.pdf) | |[Carelon Extremity CPT and Diagnoses Codes prn](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/933%20Carelon%20Extremity%20Imaging%20CPT%20and%20Diagnoses%20Codes%20prn.pdf) | |[957](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/957%20Carelon%20Genetic%20Testing%20Management%20Program%20CPT%20and%20HCPCS%20Codes%20prn.pdf) |[Carelon Genetic Testing Management Program CPT and HCPCS Codes](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/957%20Carelon%20Genetic%20Testing%20Management%20Program%20CPT%20and%20HCPCS%20Codes%20prn.pdf) | |[954](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/954%20Carelon%20Genetic%20Testing%20Management%20Program%20prn.pdf) | |[Carelon Genetic Testing Management Program prn](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/954%20Carelon%20Genetic%20Testing%20Management%20Program%20prn.pdf) | |[934](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/934%20Carelon%20Head%20and%20Neck%20Imaging%20CPT%20and%20Diagnoses%20Codes%20prn.pdf) | |[Carelon Head and Neck Imaging CPT and Diagnoses Codes prn](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/934%20Carelon%20Head%20and%20Neck%20Imaging%20CPT%20and%20Diagnoses%20Codes%20prn.pdf) | |[939](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/939%20Carelon%20Medical%20Benefits%20Management%20What%27s%20New%20Page%20prn.pdf) | |[Carelon Medical Benefits Management What's New prn](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/939%20Carelon%20Medical%20Benefits%20Management%20What%27s%20New%20Page%20prn.pdf) | |[929](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/929%20Carelon%20Oncologic%20Imaging%20CPT%2C%20HCPCS%20and%20Diagnoses%20Codes%20prn.pdf) | |[Carelon Oncologic Imaging Management Program](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/099%20Carelon%20Oncology%20Medication%20Management%20Program.pdf) | | Spine and prn](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/935%20Carelon%20Spine%20Imaging%20CPT%20and%20Diagnoses%20Codes%20prn.pdf) | |[936](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/936%20Carelon%20Vascular%20Imaging%20CPT%20and%20Diagnoses%20Codes%20prn.pdf) | |[Carelon Vascular | | Antigen Receptor Therapy for Leukemia and Lymphoma](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/066%20Chimeric%20Antigen%20Receptor%20Therapy%20for%20Leukemia%20and%20Lymphoma.pdf) | |[942](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/942%20Chimeric%20Antigen%20Receptor%20Therapy%20for%20Multiple%20Myeloma%20ABECMA%20%28Idecabtagene%20Vicleucel%29.pdf) | |[Chimeric Antigen Receptor Therapy ABECMA (Idecabtagene Vicleucel)](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/942%20Chimeric%20Antigen%20Receptor%20Therapy%20for%20Multiple%20Myeloma%20ABECMA%20%28Idecabtagene%20Vicleucel%29.pdf) | |[904](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/904%20Chromoendoscopy%20as%20an%20Adjunct%20to%20Colonoscopy%20prn.pdf) | | |[121](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/121%20Closure%20Devices%20for%20Patent%20Foramen%20Ovale%20and%20Atrial%20Septal%20Defects%20prn.pdf) the Hand and Face](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/662%20Composite%20Tissue%20Allotransplantation%20of%20the%20Hand%20and%20Face%20prn.pdf) | |[705](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/705%20Compound%20Medications%20Exclusion%20Drug%20List%20prn.pdf) | |[Compound Medications Exclusion Drug Endomicroscopy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/618%20Confocal%20Laser%20Endomicroscopy%20prn.pdf) | |[107](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/107%20Continuous%20or%20Intermittent%20Monitoring%20of%20Glucose%20in%20Interstitial%20Fluid%20and%20Artificial%20Pancreas%20Device%20Systems%20prn.pdf) | |[Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid and Artificial Pancreas Device Systems](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/107%20Continuous%20or%20Intermittent%20Monitoring%20of%20Glucose%20in%20Interstitial%20Fluid%20and%20Artificial%20Pancreas%20Device%20Systems%20prn.pdf) | |[407](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/407%20Continuous%20Passive%20Motion%20in%20the%20Home%20Setting%20prn.pdf) | |[Continuous Passive Motion in the Home Setting](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/407%20Continuous%20Passive%20Motion%20in%20the%20Home%20Setting%20prn.pdf) | |[510](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/510%20Cooling%20Devices%20Used%20in%20the%20Outpatient%20Setting%20prn.pdf) | |[Cooling Devices Used in the Outpatient Setting](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/510%20Cooling%20Devices%20Used%20in%20the%20Outpatient%20Setting%20prn.pdf) | |[905](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/905%20Corneal%20Collagen%20Cross-linking%20prn.pdf) | Collagen | |[260](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/260%20Cryoablation%20of%20Tumors%20Located%20in%20the%20Kidney%2C%20Lung%2C%20Breast%2C%20Pancreas%2C%20or%20Bone.pdf) | |[Cryoablation of Tumors Located in the Kidney, Lung, Breast, Pancreas, or Bone](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/260%20Cryoablation%20of%20Tumors%20Located%20in%20the%20Kidney%2C%20Lung%2C%20Breast%2C%20Pancreas%2C%20or%20Bone.pdf) | |[843](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/843%20Cryoablation%2C%20Radiofrequency%20Ablation%2C%20and%20Laser%20Ablation%20for%20Treatment%20of%20Chronic%20Rhinitis.pdf) | |[Cryoablation, Radiofrequency Ablation, and Laser Chronic | |[633](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/633%20Cryosurgical%20Ablation%20of%20Primary%20or%20Metastatic%20Liver%20Tumors%20prn.pdf) | |[Cryosurgical Ablation of Primary or Tumors](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/633%20Cryosurgical%20Ablation%20of%20Primary%20or%20Metastatic%20Liver%20Tumors%20prn.pdf) | |[271](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/271%20Decompression%20of%20the%20Intervertebral%20Disc%20Using%20Laser%20Energy%20-%20or%20Radiofrequency%20Coblation%20-%20Nucleoplasty%20prn.pdf) | |[Decompression of the Intervertebral Disc Using Laser Energy - or Radiofrequency Coblation - Nucleoplasty](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/271%20Decompression%20of%20the%20Intervertebral%20Disc%20Using%20Laser%20Energy%20-%20or%20Radiofrequency%20Coblation%20-%20Nucleoplasty%20prn.pdf) | |[473](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/473%20Deep%20Brain%20Stimulation%20prn.pdf) | | |[264](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/264%20Diagnosis%20and%20Management%20of%20Idiopathic%20Environmental%20Intolerance%20or%20Clinical%20Ecology%20prn.pdf) | |[Diagnosis and Management of Idiopathic Environmental Intolerance or Clinical Ecology](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/264%20Diagnosis%20and%20Management%20of%20Idiopathic%20Environmental%20Intolerance%20or%20Clinical%20Ecology%20prn.pdf) | |[352](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/352%20Diagnosis%20and%20Treatment%20of%20Chronic%20Cerebrospinal%20Venous%20Insufficiency%20in%20Multiple%20Sclerosis%20prn.pdf) | |[Diagnosis and Treatment of Chronic Insufficiency in Multiple Sclerosis](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/352%20Diagnosis%20and%20Treatment%20of%20Chronic%20Cerebrospinal%20Venous%20Insufficiency%20in%20Multiple%20Sclerosis%20prn.pdf) | |[320](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/320%20Diagnosis%20and%20Treatment%20of%20Sacroiliac%20Joint%20Pain.pdf) Sacroiliac Health Technologies Diagnostic Applications](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/175%20Digital%20Health%20Technologies%20Diagnostic%20Applications.pdf) | |[090](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/090%20Digital%20Health%20Technologies%20Therapeutic%20Applications.pdf) | |[Digital Health Technologies Therapeutic Applications](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/090%20Digital%20Health%20Technologies%20Therapeutic%20Applications.pdf) | |[947](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/947%20Digital%20Health%20Therapies%20for%20Attention%20Deficit.pdf) | |[Digital Health Therapies for Attention Deficit](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/947%20Digital%20Health%20Therapies%20for%20Attention%20Deficit.pdf) |[411](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/411%20Directory%20of%20Documents.pdf) | |[Directory of Documents](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/411%20Directory%20of%20Documents.pdf) | |[918](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/918%20Dopamine%20Transporter%20Imaging%20with%20Single%20Photon%20Emission%20Computed%20Tomography%20prn.pdf) Photon Emission Computed Tomography](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/918%20Dopamine%20Transporter%20Imaging%20with%20Single%20Photon%20Emission%20Computed%20Tomography%20prn.pdf) | |[049](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/049%20Drug%20Management%20%26%20Retail%20Pharmacy%20Prior%20Authorization%20Policy.pdf) | |[Drug Management & Retail Pharmacy Prior Authorization Policy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/049%20Drug%20Management%20%26%20Retail%20Pharmacy%20Prior%20Authorization%20Policy.pdf) | |[251](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/251%20Drug%20Management%20and%20Prior%20Authorization%20prn.pdf) | |[Drug Management and Prior Authorization](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/251%20Drug%20Management%20and%20Prior%20Authorization%20prn.pdf) | |[674](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/674%20Drug%20Testing%20in%20Pain%20Management%20and%20Substance%20Use%20Disorder%20Treatment%20prn.pdf) | |[Drug Testing in Pain Management and Substance Use Disorder Treatment](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/674%20Drug%20Testing%20in%20Pain%20Management%20and%20Substance%20Use%20Disorder%20Treatment%20prn.pdf) | |[408](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/408%20Drugs%20for%20Cystic%20Fibrosis%20prn.pdf) | |[Drugs for Cystic Weight | | |[Dry for chronic pain conditions](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/164%20Dry%20Hydrotherapy%20for%20chronic%20pain%20conditions.pdf) | |[792](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/792%20Dry%20Needling%20and%20Trigger%20Point%20Injections%20for%20Myofascial%20Pain%20prn.pdf) | |[Dry Needling and Trigger Point Injections Myofascial | |[Durable Vertebral | | Form medication prior auth instruction](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/023%20E%20Form%20medication%20prior%20auth%20instruction%20prn.pdf) | |[499](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/499%20Electrical%20Bone%20Growth%20Stimulation%20of%20the%20Appendicular%20Skeleton%20prn.pdf) | |[Electrical Bone Growth Stimulation of the Appendicular Skeleton](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/499%20Electrical%20Bone%20Growth%20Stimulation%20of%20the%20Appendicular%20Skeleton%20prn.pdf) | |[157](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/157%20Electrical%20Stimulation%20Devices%20for%20Psychiatric%20and%20Neurological%20Conditions%20prn.pdf) | |[Electrical Stimulation Devices for Psychiatric and Neurological Conditions](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/157%20Electrical%20Stimulation%20Devices%20for%20Psychiatric%20and%20Neurological%20Conditions%20prn.pdf) | |[302](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/302%20Electrical%20Stimulation%20for%20the%20Treatment%20of%20Arthritis%20prn.pdf) | |[Electrical Stimulation for the Treatment of Arthritis](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/302%20Electrical%20Stimulation%20for%20the%20Treatment%20of%20Arthritis%20prn.pdf) | |[498](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/498%20Electrical%20Stimulation%20of%20the%20Spine%20as%20an%20Adjunct%20to%20Spinal%20Fusion%20Procedures%20prn.pdf) | |[Electrical Stimulation of the Spine as an Adjunct to Spinal Fusion Procedures](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/498%20Electrical%20Stimulation%20of%20the%20Spine%20as%20an%20Adjunct%20to%20Spinal%20Fusion%20Procedures%20prn.pdf) | |[203](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/203%20Electromagnetic%20Navigation%20Bronchoscopy%20prn.pdf) | |[Electromagnetic Navigation Bronchoscopy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/203%20Electromagnetic%20Navigation%20Bronchoscopy%20prn.pdf) Conduction Studies](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/701%20Electromyography%20and%20Nerve%20Conduction%20Studies%20prn.pdf) | |[655](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/655%20Electrostimulation%20and%20Electromagnetic%20Therapy%20for%20Treating%20Wounds%20prn.pdf) | |[Electrostimulation and Therapy for Treating Wounds](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/655%20Electrostimulation%20and%20Electromagnetic%20Therapy%20for%20Treating%20Wounds%20prn.pdf) | |[009](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/009%20Elzonris%20%28tagraxofusp-erzs%29%20for%20the%20Treatment%20of%20Blastic%20Plasmacytoid%20Dendritic%20Cell%20Neoplasm%20prn.pdf) | |[Elzonris (tagraxofusp-erzs) for Cell Neoplasm](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/009%20Elzonris%20%28tagraxofusp-erzs%29%20for%20the%20Treatment%20of%20Blastic%20Plasmacytoid%20Dendritic%20Cell%20Neoplasm%20prn.pdf) | |[928](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/928%20Elzonris%20Prior%20Authorization%20Request%20Form%20MP%20009%20prn.pdf) | |[Elzonris Form MP 009](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/928%20Elzonris%20Prior%20Authorization%20Request%20Form%20MP%20009%20prn.pdf) | |[648](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/648%20End-Diastolic%20Pneumatic%20Compression%20Boot%20as%20a%20Treatment%20of%20Peripheral%20Vascular%20Disease%20or%20Lymphedema%20prn.pdf) | |[End-Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/648%20End-Diastolic%20Pneumatic%20Compression%20Boot%20as%20a%20Treatment%20of%20Peripheral%20Vascular%20Disease%20or%20Lymphedema%20prn.pdf) | |[715](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/715%20Endobronchial%20Ultrasound%20for%20Diagnosis%20and%20Staging%20of%20Lung%20Cancer%20prn.pdf) | |[Endobronchial Ultrasound for Diagnosis and Staging of Lung Cancer](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/715%20Endobronchial%20Ultrasound%20for%20Diagnosis%20and%20Staging%20of%20Lung%20Cancer%20prn.pdf) | | | External Counterpulsation - EECP - for Chronic Stable Angina Cell Cytology in Breast Cancer Risk Assessment and High-Risk Patient Management - Ductal Lavage and Suction Collection Systems](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/492%20Epithelial%20Cell%20Cytology%20in%20Breast%20Cancer%20Risk%20Assessment%20and%20High-Risk%20Patient%20Management%20-%20Ductal%20Lavage%20and%20Suction%20Collection%20Systems%20prn.pdf) | | Musculoskeletal Conditions](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/081%20Extracorporeal%20Shock%20Wave%20Treatment%20for%20Plantar%20Fasciitis%20and%20Other%20Musculoskeletal%20Conditions%20prn.pdf) | |[613](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/613%20Eyelid%20Thermal%20Pulsation%20for%20the%20Treatment%20of%20Dry%20Eye%20Syndrome%20prn.pdf) | |[Eyelid Thermal Pulsation for the of Dry Eye Syndrome](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/613%20Eyelid%20Thermal%20Pulsation%20for%20the%20Treatment%20of%20Dry%20Eye%20Syndrome%20prn.pdf) | |[174](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/174%20Facet%20Arthroplasty%20prn.pdf) | |[Facet Arthroplasty](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/174%20Facet%20Arthroplasty%20prn.pdf) | |[556](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/556%20Fecal%20Analysis%20in%20the%20Diagnosis%20of%20Intestinal%20Dysbiosis%20prn.pdf) | |[Fecal Analysis in Dysbiosis](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/556%20Fecal%20Analysis%20in%20the%20Diagnosis%20of%20Intestinal%20Dysbiosis%20prn.pdf) Therapies Bladder | Therapies for Duchenne for |[911](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/911%20Gene%20Therapy%20for%20Inherited%20Retinal%20Dystrophy%20Luxturna%20prn.pdf) |[Gene |[Handheld Acute Lymphoblastic Leukemia](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/076%20Hematopoietic%20Cell%20Transplantation%20for%20Acute%20Lymphoblastic%20Leukemia%20prn.pdf) | |[150](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/150%20Hematopoietic%20Cell%20Transplantation%20for%20Acute%20Myeloid%20Leukemia%20prn.pdf) | |[Hematopoietic Cell Transplantation for Acute Myeloid Leukemia](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/150%20Hematopoietic%20Cell%20Transplantation%20for%20Acute%20Myeloid%20Leukemia%20prn.pdf) | |[192](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/192%20Hematopoietic%20Cell%20Transplantation%20for%20Autoimmune%20Diseases%20prn.pdf) | |[Hematopoietic Cell Transplantation for Autoimmune Diseases](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/192%20Hematopoietic%20Cell%20Transplantation%20for%20Autoimmune%20Diseases%20prn.pdf) | |[074](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/074%20Hematopoietic%20Cell%20Transplantation%20for%20Chronic%20Lymphocytic%20Leukemia%20and%20Small%20Lymphocytic%20Lymphoma%20prn.pdf) | |[Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/074%20Hematopoietic%20Cell%20Transplantation%20for%20Chronic%20Lymphocytic%20Leukemia%20and%20Small%20Lymphocytic%20Lymphoma%20prn.pdf) | |[212](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/212%20Hematopoietic%20Cell%20Transplantation%20for%20Chronic%20Myeloid%20Leukemia%20prn.pdf) | |[Hematopoietic Transplantation for Chronic | |[205](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/205%20Hematopoietic%20Cell%20Transplantation%20for%20CNS%20Embryonal%20Tumors%20and%20Ependymoma%20prn.pdf) | |[Hematopoietic Cell Transplantation Tumors and Ependymoma](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/205%20Hematopoietic%20Cell%20Transplantation%20for%20CNS%20Embryonal%20Tumors%20and%20Ependymoma%20prn.pdf) | |[204](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/204%20Hematopoietic%20Cell%20Transplantation%20for%20Epithelial%20Ovarian%20Cancer%20prn.pdf) | |[Hematopoietic Cell Transplantation for Epithelial Ovarian Cancer](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/204%20Hematopoietic%20Cell%20Transplantation%20for%20Epithelial%20Ovarian%20Cancer%20prn.pdf) | |[207](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/207%20Hematopoietic%20Cell%20Transplantation%20for%20Hodgkin%20Lymphoma%20prn.pdf) | |[Hematopoietic Cell Transplantation for Hodgkin Lymphoma](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/207%20Hematopoietic%20Cell%20Transplantation%20for%20Hodgkin%20Lymphoma%20prn.pdf) | |[191](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/191%20Hematopoietic%20Cell%20Transplantation%20for%20Miscellaneous%20Solid%20Tumors%20in%20Adults%20prn.pdf) | |[Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/191%20Hematopoietic%20Cell%20Transplantation%20for%20Miscellaneous%20Solid%20Tumors%20in%20Adults%20prn.pdf) | |[143](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/143%20Hematopoietic%20Cell%20Transplantation%20for%20Non-Hodgkin%20Lymphomas%20prn.pdf) | |[Hematopoietic Cell Transplantation for Non-Hodgkin Lymphomas](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/143%20Hematopoietic%20Cell%20Transplantation%20for%20Non-Hodgkin%20Lymphomas%20prn.pdf) | |[075](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/075%20Hematopoietic%20Cell%20Transplantation%20for%20Plasma%20Cell%20Dyscracias%2C%20Including%20Multiple%20Myeloma%20and%20POEMS%20Syndrome%20prn.pdf) | |[Hematopoietic Cell Transplantation for Plasma Cell Dyscracias, Including Multiple Myeloma and POEMS Syndrome](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/075%20Hematopoietic%20Cell%20Transplantation%20for%20Plasma%20Cell%20Dyscracias%2C%20Including%20Multiple%20Myeloma%20and%20POEMS%20Syndrome%20prn.pdf) | |[181](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/181%20Hematopoietic%20Cell%20Transplantation%20for%20Primary%20Amyloidosis%20prn.pdf) | |[Hematopoietic Cell Transplantation for Primary Amyloidosis](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/181%20Hematopoietic%20Cell%20Transplantation%20for%20Primary%20Amyloidosis%20prn.pdf) | |[208](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/208%20Hematopoietic%20Cell%20Transplantation%20for%20Solid%20Tumors%20of%20Childhood%20prn.pdf) | |[Hematopoietic Cell Transplantation for Solid Tumors of Childhood](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/208%20Hematopoietic%20Cell%20Transplantation%20for%20Solid%20Tumors%20of%20Childhood%20prn.pdf) | |[247](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/247%20Hematopoietic%20Cell%20Transplantation%20in%20the%20Treatment%20of%20Germ-Cell%20Tumors%20prn.pdf) | |[Hematopoietic Cell Transplantation in the Treatment of Germ-Cell | | |[296](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/296%20Home%20Total%20Parenteral%20Nutrition%20TPN%20prn.pdf) |[Home Total Parenteral Nutrition TPN](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/296%20Home%20Total%20Parenteral%20Nutrition%20TPN%20prn.pdf) | |[016](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/016%20Homocysteine%20Testing%20in%20the%20Screening%2C%20Diagnosis%2C%20and%20Management%20of%20Cardiovascular%20Disease%20and%20Venous%20Thromboembolic%20Disease%20prn.pdf) | |[Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disease](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/016%20Homocysteine%20Testing%20in%20the%20Screening%2C%20Diagnosis%2C%20and%20Management%20of%20Cardiovascular%20Disease%20and%20Venous%20Thromboembolic%20Disease%20prn.pdf) | Intra-Abdominal and Pelvic | | |[Hypoactive Sexual Desire Disorder (HSDD) Policy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/131%20Hypoactive%20Sexual%20Desire%20Disorder%20%28HSDD%29%20Policy%20prn.pdf) |[555](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/555%20Identification%20of%20Microorganisms%20Using%20Nucleic%20Acid%20Probe%20prn.pdf) |[Identification | | Cell Function Assay in Solid Transplantation](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/182%20Immune%20Cell%20Function%20Assay%20in%20Solid%20Organ%20Transplantation%20prn.pdf) | |[Inhaled Nitric Oxide as a Treatment of Hypoxic Respiratory Failure in Neonates](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/100%20Inhaled%20Nitric%20Oxide%20as%20a%20Treatment%20of%20Hypoxic%20Respiratory%20Failure%20in%20Neonates%20prn.pdf) | |[017](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/017%20Injectable%20Asthma%20Medications%20prn.pdf) | |[Injectable Asthma Medications](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/017%20Injectable%20Asthma%20Medications%20prn.pdf) | |[471](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/471%20Injectable%20Bulking%20Agents%20for%20the%20Treatment%20of%20Urinary%20and%20Fecal%20Incontinence%20prn.pdf) | |[Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/471%20Injectable%20Bulking%20Agents%20for%20the%20Treatment%20of%20Urinary%20and%20Fecal%20Incontinence%20prn.pdf) | |[071](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/071%20Injectable%20Specialty%20Medication%20Coverage%20prn.pdf) | |[Injectable Specialty | |[052](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/052%20Interferons%20Alpha%20and%20Gamma%20prn.pdf) |[Interferons and | | |[Intravenous Anesthetics for the Treatment of Chronic Pain](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/291%20Intravenous%20Anesthetics%20for%20the%20Treatment%20of%20Chronic%20Pain%20prn.pdf) | |[171](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/171%20Intravenous%20Antibiotic%20Therapy%20and%20Associated%20Diagnostic%20Testing%20for%20Lyme%20Disease%20prn.pdf) | |[Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/171%20Intravenous%20Antibiotic%20Therapy%20and%20Associated%20Diagnostic%20Testing%20for%20Lyme%20Disease%20prn.pdf) | |[272](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/272%20Intravitreal%20and%20Punctum%20Corticosteroid%20Implants%20prn.pdf) | |[Intravitreal |[324](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/324%20Islet%20Transplantation%20prn.pdf) |[Islet |[Laparoscopic Techniques Uterine Fibroids](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/244%20Laparoscopic%20and%20Transcervical%20Techniques%20for%20the%20Myolysis%20of%20Uterine%20Fibroids%20prn.pdf) | |[948](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/948%20Laser%20Interstitial%20Thermal%20Therapy%20for%20Neurological%20Conditions.pdf) | |[Laser Interstitial Thermal Therapy for Neurological Conditions](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/948%20Laser%20Interstitial%20Thermal%20Therapy%20for%20Neurological%20Conditions.pdf) | |[461](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/461%20Laser%20Treatment%20of%20Active%20Acne%20prn.pdf) | |[Laser Treatment of Active Acne](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/461%20Laser%20Treatment%20of%20Active%20Acne%20prn.pdf) | | Treatment Onychomycosis](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/562%20Laser%20Treatment%20of%20Onychomycosis%20prn.pdf) Pacemakers](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/038%20Leadless%20Cardiac%20Pacemakers%20prn.pdf) | |[334](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/334%20Left-Atrial%20Appendage%20Closure%20Devices%20for%20Stroke%20Prevention%20in%20Atrial%20Fibrillation%20prn.pdf) | Appendage Devices Lung Transplant](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/015%20Lung%20and%20Lobar%20Lung%20Transplant%20prn.pdf) | |[364](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/364%20Lung%20Volume%20Reduction%20Surgery%20for%20Severe%20Emphysema%20prn.pdf) | |[Lung Volume Reduction Surgery for Severe Emphysema](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/364%20Lung%20Volume%20Reduction%20Surgery%20for%20Severe%20Emphysema%20prn.pdf) | |[483](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/483%20Manipulation%20under%20Anesthesia%20prn.pdf) | |[Manipulation under Anesthesia](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/483%20Manipulation%20under%20Anesthesia%20prn.pdf) | |[365](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/365%20Manual%20and%20Power%20Operated%20Wheelchairs.pdf) and Power Operated Wheelchairs](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/365%20Manual%20and%20Power%20Operated%20Wheelchairs.pdf) | |[434](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/434%20Massachusetts%20Standard%20Form%20for%20Medication%20Prior%20Authorization%20Requests%20prn.pdf) | |[Massachusetts Standard Form for Medication Prior Authorization Requests](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/434%20Massachusetts%20Standard%20Form%20for%20Medication%20Prior%20Authorization%20Requests%20prn.pdf) | |[163](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/163%20Maternal%20Serum%20Biomarkers%20for%20Prediction%20of%20Adverse%20Obstetric%20Outcomes.pdf) | |[Maternal Serum Biomarkers | |[524](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/524%20Measurement%20of%20Exhaled%20Nitric%20Oxide%20and%20Exhaled%20Breath%20Condensate%20in%20the%20Diagnosis%20and%20Management%20of%20Respiratory%20Disorders%20prn.pdf) | |[Measurement of Exhaled Nitric Oxide and Exhaled Breath Condensate in the Diagnosis and Management of Respiratory Disorders](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/524%20Measurement%20of%20Exhaled%20Nitric%20Oxide%20and%20Exhaled%20Breath%20Condensate%20in%20the%20Diagnosis%20and%20Management%20of%20Respiratory%20Disorders%20prn.pdf) | |[558](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/558%20Measurement%20of%20Lipoprotein-Associated%20Phospholipase%20A2%20-%20Lp-PLA2%20-%20in%20the%20Assessment%20of%20Cardiovascular%20Risk%20prn.pdf) | |[Measurement of Lipoprotein-Associated Phospholipase A2 - - the of Cardiovascular Risk](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/558%20Measurement%20of%20Lipoprotein-Associated%20Phospholipase%20A2%20-%20Lp-PLA2%20-%20in%20the%20Assessment%20of%20Cardiovascular%20Risk%20prn.pdf) | |[917](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/917%20Measurement%20of%20Serum%20Antibodies%20to%20Selected%20Biologic%20Agents%20prn.pdf) | |[Measurement of Serum Antibodies to Selected Biologic Agents](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/917%20Measurement%20of%20Serum%20Antibodies%20to%20Selected%20Biologic%20Agents%20prn.pdf) | |[379](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/379%20Medical%20and%20Surgical%20Management%20of%20Obesity%20including%20Anorexiants%20prn.pdf) | |[Medical and Surgical Management of Obesity including Anorexiants](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/379%20Medical%20and%20Surgical%20Management%20of%20Obesity%20including%20Anorexiants%20prn.pdf) | |[034](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/034%20Medical%20Benefit%20Prior%20Authorization%20Medication%20List%20prn.pdf) | |[Medical Benefit Prior Authorization Medication List](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/034%20Medical%20Benefit%20Prior%20Authorization%20Medication%20List%20prn.pdf) |[999](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/999%20Medical%20Policy%20Updates%20prn.pdf) | |[Medical Policy Updates](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/999%20Medical%20Policy%20Updates%20prn.pdf) | Assessment Services](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/400%20Medical%20Technology%20Assessment%20NonCovered%20Services%20prn.pdf) | |[923](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/923%20Medicare%20Advantage%20High%20Technology%20Radiology%20%26%20Sleep%20Disorder%20Management%20Redirect%20prn.pdf) | |[Medicare Advantage High Technology Radiology & Sleep Disorder Management Redirect](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/923%20Medicare%20Advantage%20High%20Technology%20Radiology%20%26%20Sleep%20Disorder%20Management%20Redirect%20prn.pdf) | |[132](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/132%20Medicare%20Advantage%20Management.pdf) | |[Medicare Advantage Management](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/132%20Medicare%20Advantage%20Management.pdf) | |[020](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/020%20Medicare%20Advantage%20Part%20B%20Step%20Therapy%20prn.pdf) | Advantage Part B Step Therapy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/020%20Medicare%20Advantage%20Part%20B%20Step%20Therapy%20prn.pdf) | |[125](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/125%20Medicare%20Advantage%20Part%20B%20Utilization%20Management.pdf) | |[Medicare Advantage Part B Utilization Management](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/125%20Medicare%20Advantage%20Part%20B%20Utilization%20Management.pdf) | |[442](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/442%20Medicare%20Part%20D%20Coverage%20Determination%20Request%20Form%20prn.pdf) | |[Medicare Part D Coverage Determination Request Form](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/442%20Medicare%20Part%20D%20Coverage%20Determination%20Request%20Form%20prn.pdf) | |[083](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/083%20Medications%20for%20Sickle%20Cell%20and%20Beta%20Thalassemia%20prn.pdf) | |[Medications for Sickle Cell and Beta | |[274](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/274%20Methadone%20Treatment%20and%20Intensive%20Detoxification%20or%20Ultra-Rapid%20Detoxification%20for%20Opiate%20Addiction%20prn.pdf) | |[Methadone and Intensive Detoxification Ultra-Rapid Detoxification for Opiate Addiction](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/274%20Methadone%20Treatment%20and%20Intensive%20Detoxification%20or%20Ultra-Rapid%20Detoxification%20for%20Opiate%20Addiction%20prn.pdf) | |[840](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/840%20Methotrexate%20Step%20Therapy.pdf) Density Studies](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/450%20Mineral%20Density%20Studies%20prn.pdf) | |[744](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/744%20Minimally%20Invasive%20and%20surgical%20treatment%20options%20for%20Benign%20Prostatic%20Hyperplasia.pdf) | |[Minimally Invasive and surgical treatment options for Benign Prostatic Hyperplasia](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/744%20Minimally%20Invasive%20and%20surgical%20treatment%20options%20for%20Benign%20Prostatic%20Hyperplasia.pdf) | |[029](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/029%20Molecular%20Testing%20in%20the%20Management%20of%20Pulmonary%20Nodules%20prn.pdf) | |[Molecular Testing in the Management of Pulmonary Nodules](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/029%20Molecular%20Testing%20in%20the%20Management%20of%20Pulmonary%20Nodules%20prn.pdf) | |[154](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/154%20Monitored%20Anesthesia%20Care%20-%20MAC%20prn.pdf) | |[Monitored Anesthesia Care - MAC](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/154%20Monitored%20Anesthesia%20Care%20-%20MAC%20prn.pdf) | |[MS Policy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/839%20Multiple%20Sclerosis%20Step%20Therapy.pdf) | |[677](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/677%20Multibiomarker%20Disease%20Activity%20Blood%20Test%20for%20Rheumatoid%20Arthritis%20prn.pdf) | Rheumatoid Arthritis](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/677%20Multibiomarker%20Disease%20Activity%20Blood%20Test%20for%20Rheumatoid%20Arthritis%20prn.pdf) | |[249](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/249%20Multimarker%20Serum%20Testing%20Related%20to%20Ovarian%20Cancer%20prn.pdf) | |[Multimarker Serum Testing Related Digital Skin Lesion Analysis](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/748%20Multispectral%20Digital%20Skin%20Lesion%20Analysis%20prn.pdf) | |[711](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/711%20Multitarget%20Polymerase%20Chain%20Reaction%20Testing%20for%20Diagnosis%20of%20Bacterial%20Vaginosis%20prn.pdf) | |[Multitarget Polymerase Chain Reaction Testing for Diagnosis of Bacterial Vaginosis](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/711%20Multitarget%20Polymerase%20Chain%20Reaction%20Testing%20for%20Diagnosis%20of%20Bacterial%20Vaginosis%20prn.pdf) | |[062](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/062%20Mupirocin%20Step%20Policy%20prn.pdf) | |[Mupirocin Step Policy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/062%20Mupirocin%20Step%20Policy%20prn.pdf) | |[576](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/576%20Myocardial%20Sympathetic%20Innervation%20Imaging%20in%20Patients%20with%20Heart%20Failure%20prn.pdf) | |[Myocardial Sympathetic Innervation Imaging in Patients with Heart Failure](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/576%20Myocardial%20Sympathetic%20Innervation%20Imaging%20in%20Patients%20with%20Heart%20Failure%20prn.pdf) | |[227](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/227%20Myoelectric%20Prosthetic%20and%20Components%20for%20the%20Upper%20Limb%20prn.pdf) | |[Myoelectric Prosthetic and Components for the Upper Limb](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/227%20Myoelectric%20Prosthetic%20and%20Components%20for%20the%20Upper%20Limb%20prn.pdf) | |[596](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/596%20Navigated%20Transcranial%20Magnetic%20Stimulation%20prn.pdf) | |[Navigated Transcranial Magnetic Stimulation](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/596%20Navigated%20Transcranial%20Magnetic%20Stimulation%20prn.pdf) | |[543](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/543%20Negative%20Pressure%20Wound%20Therapy%20in%20the%20Outpatient%20Setting%20prn.pdf) | |[Negative Pressure Wound Therapy in the Outpatient Setting](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/543%20Negative%20Pressure%20Wound%20Therapy%20in%20the%20Outpatient%20Setting%20prn.pdf) | |[393](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/393%20Nerve%20Fiber%20Density%20Measurement%20prn.pdf) | |[Nerve Fiber Density Measurement](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/393%20Nerve%20Fiber%20Density%20Measurement%20prn.pdf) | |[590](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/590%20Nerve%20Graft%20in%20Association%20with%20Radical%20Prostatectomy%20prn.pdf) | |[Nerve Graft in Association with Radical | | Therapy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/914%20Neural%20Therapy%20prn.pdf) | - Duplex Scans](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/691%20Non-Invasive%20Vascular%20Studies%20-%20Duplex%20Scans%20prn.pdf) |[657](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/657%20Noncontact%20Ultrasound%20Treatment%20for%20Wounds%20prn.pdf) |[Noncontact Treatment for Wounds](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/657%20Noncontact%20Ultrasound%20Treatment%20for%20Wounds%20prn.pdf) | |[Noncovered Drug List](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/433%20Noncovered%20Drug%20List%20prn.pdf) | |[921](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/921%20Noninvasive%20Techniques%20for%20the%20Evaluation%20and%20Monitoring%20of%20Patients%20With%20Chronic%20Liver%20Disease%20prn.pdf) | |[Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/921%20Noninvasive%20Techniques%20for%20the%20Evaluation%20and%20Monitoring%20of%20Patients%20With%20Chronic%20Liver%20Disease%20prn.pdf) | |[123](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/123%20Nononcologic%20Uses%20of%20Rituximab.pdf) | |[Nononcologic Uses of Rituximab](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/123%20Nononcologic%20Uses%20of%20Rituximab.pdf) | |[283](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/283%20Novel%20Biomarkers%20in%20Risk%20Assessment%20and%20Management%20of%20Cardiovascular%20Disease%20prn.pdf) | |[Novel Biomarkers in Risk Assessment and Management of Cardiovascular Disease](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/283%20Novel%20Biomarkers%20in%20Risk%20Assessment%20and%20Management%20of%20Cardiovascular%20Disease%20prn.pdf) | |[745](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/745%20Nutrient%20-%20Nutritional%20Panel%20Testing%20prn.pdf) | |[Nutrient - Nutritional Panel Testing](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/745%20Nutrient%20-%20Nutritional%20Panel%20Testing%20prn.pdf) | |[007](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/007%20Obstetrical%20Ultrasound%20and%20Ultrasound%20for%20Family%20Planning%20%20prn.pdf) | |[Obstetrical Ultrasound and Ultrasound for Family Planning](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/007%20Obstetrical%20Ultrasound%20and%20Ultrasound%20for%20Family%20Planning%20%20prn.pdf) | |[237](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/237%20Occipital%20Nerve%20Stimulation%20prn.pdf) | |[Occipital Nerve Stimulation](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/237%20Occipital%20Nerve%20Stimulation%20prn.pdf) | and Thoracoscopic Approaches to Treat Atrial Fibrillation - Maze and Related Procedures](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/356%20Open%20and%20Thoracoscopic%20Approaches%20to%20Treat%20Atrial%20Fibrillation%20-%20Maze%20and%20Related%20Procedures%20prn.pdf) | |[346](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/346%20Ophthalmic%20Prostaglandins%20prn.pdf) | |[Ophthalmic Prostaglandins](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/346%20Ophthalmic%20Prostaglandins%20prn.pdf) | |[053](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/053%20Ophthalmologic%20Techniques%20That%20Evaluate%20the%20Posterior%20Segment%20for%20Glaucoma%20prn.pdf) | |[Ophthalmologic That the Segment for Glaucoma](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/053%20Ophthalmologic%20Techniques%20That%20Evaluate%20the%20Posterior%20Segment%20for%20Glaucoma%20prn.pdf) | |[102](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/102%20Opioid%20Medication%20Management%20prn.pdf) | |[Opioid Medication Management](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/102%20Opioid%20Medication%20Management%20prn.pdf) | |[915](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/915%20Optical%20Coherence%20Tomography%20for%20Imaging%20of%20Coronary%20Arteries%20prn.pdf) | Coherence for of Coronary Arteries](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/915%20Optical%20Coherence%20Tomography%20for%20Imaging%20of%20Coronary%20Arteries%20prn.pdf) | |[084](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/084%20Optical%20Coherence%20Tomography%20of%20the%20Anterior%20Eye%20Segment%20prn.pdf) | |[Optical Coherence Tomography of the |[179](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/179%20Orthognathic%20Surgery.pdf) | Applications of Stem Cell Therapy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/254%20Orthopedic%20Applications%20of%20Stem%20Cell%20Therapy%20prn.pdf) | |[611](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/611%20Orthoptic%20Training%20for%20the%20Treatment%20of%20Vision%20or%20Learning%20Disabilities%20prn.pdf) | |[Orthoptic Training for the Treatment of Vision or Learning Disabilities](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/611%20Orthoptic%20Training%20for%20the%20Treatment%20of%20Vision%20or%20Learning%20Disabilities%20prn.pdf) | |[550](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/550%20Orthotics%20for%20Progressive%20Scoliosis%20prn.pdf) | |[Orthotics for Progressive Scoliosis](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/550%20Orthotics%20for%20Progressive%20Scoliosis%20prn.pdf) | |[120](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/120%20Oscillatory%20Devices%20for%20the%20Treatment%20of%20Cystic%20Fibrosis%20and%20Other%20Respiratory%20Conditions%20prn.pdf) | |[Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/120%20Oscillatory%20Devices%20for%20the%20Treatment%20of%20Cystic%20Fibrosis%20and%20Other%20Respiratory%20Conditions%20prn.pdf) | Pediatric Pain Rehabilitation Centers](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/158%20Outpatient%20Pediatric%20Pain%20Rehabilitation%20Centers.pdf) | |[072](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/072%20Outpatient%20Prior%20Authorization%20Code%20List%20prn.pdf) | Prior Code and Internal Iliac Vein Endovascular Occlusion as a Treatment of Pelvic Congestion Syndrome](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/266%20Ovarian%20and%20Internal%20Iliac%20Vein%20Endovascular%20Occlusion%20as%20a%20Treatment%20of%20Pelvic%20Congestion%20Syndrome%20prn.pdf) | |[170](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/170%20Overactive%20Bladder%20Medications%20prn.pdf) | |[Overactive Bladder Medications](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/170%20Overactive%20Bladder%20Medications%20prn.pdf) | |[517](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/517%20Paraspinal%20Surface%20Electromyography%20-%20SEMG%20-%20to%20Evaluate%20and%20Monitor%20Back%20Pain%20prn.pdf) | |[Paraspinal Surface Electromyography - SEMG - to Evaluate and Monitor Back Pain](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/517%20Paraspinal%20Surface%20Electromyography%20-%20SEMG%20-%20to%20Evaluate%20and%20Monitor%20Back%20Pain%20prn.pdf) | |[045](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/045%20Pathogen%20Panel%20Testing.pdf) | |[Pathogen Panel Testing](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/045%20Pathogen%20Panel%20Testing.pdf) | |[721](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/721%20Patient-Actuated%20End%20Range%20Motion%20Stretching%20Devices%20prn.pdf) | End Motion Stretching Devices](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/721%20Patient-Actuated%20End%20Range%20Motion%20Stretching%20Devices%20prn.pdf) | |[706](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/706%20Patient-Specific%20Instrumentation%20%28eg%2C%20Cutting%20Guides%29%20for%20Joint%20Arthroplasty%20prn.pdf) | |[Patient-Specific Instrumentation (eg, Cutting Guides) for Joint Arthroplasty](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/706%20Patient-Specific%20Instrumentation%20%28eg%2C%20Cutting%20Guides%29%20for%20Joint%20Arthroplasty%20prn.pdf) | |[470](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/470%20Pelvic%20Floor%20Stimulation%20as%20a%20Treatment%20of%20Urinary%20Incontinence%20and%20Fecal%20Incontinence%20prn.pdf) | |[Pelvic Floor Stimulation as a Treatment of Urinary Incontinence and Fecal Incontinence](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/470%20Pelvic%20Floor%20Stimulation%20as%20a%20Treatment%20of%20Urinary%20Incontinence%20and%20Fecal%20Incontinence%20prn.pdf) | |[922](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/922%20Percutaneous%20Electrical%20Nerve%20Field%20Stimulation%20for%20Functional%20Abdominal%20Pain%20Disorders.pdf) | |[Percutaneous Electrical Nerve Field Stimulation for Functional Abdominal Pain Disorders](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/922%20Percutaneous%20Electrical%20Nerve%20Field%20Stimulation%20for%20Functional%20Abdominal%20Pain%20Disorders.pdf) | |[172](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/172%20Percutaneous%20Electrical%20Nerve%20Stimulation%20-%20PENS%20-%20and%20Percutaneous%20Neuromodulation%20Therapy%20-%20PNT%20prn.pdf) | |[Percutaneous Electrical Nerve Stimulation - PENS - and Percutaneous Neuromodulation of Achalasia](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/451%20Peroral%20Endoscopic%20Myotomy%20for%20Treatment%20of%20Esophageal%20Achalasia%20prn.pdf) |[344](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/344%20Pharmacy%20Hepatitis%20C%20Medication%20Management%20prn.pdf) |[Pharmacy Hepatitis C Medication Management](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/344%20Pharmacy%20Hepatitis%20C%20Medication%20Management%20prn.pdf) |[955](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/955%20Phrenic%20Nerve%20Stimulation%20for%20Central%20Sleep%20Apnea%20prn.pdf) |[Phrenic for Central Sleep | | Exchange](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/466%20Plasma%20Exchange%20prn.pdf) Repair](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/528%20Plugs%20for%20Fistula%20Repair%20prn.pdf) |[354](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/354%20Pneumatic%20Compression%20Pumps%20for%20Treatment%20of%20Lymphedema%20and%20Venous%20Ulcers%20prn.pdf) Lymphedema and Venous Ulcers](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/354%20Pneumatic%20Compression%20Pumps%20for%20Treatment%20of%20Lymphedema%20and%20Venous%20Ulcers%20prn.pdf) | |[541](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/541%20Postsurgical%20Outpatient%20Use%20of%20Limb%20Compression%20Devices%20for%20Venous%20Thromboembolism%20Prophylaxis%20prn.pdf) | |[Postsurgical Outpatient Use Limb for Thromboembolism Prophylaxis](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/541%20Postsurgical%20Outpatient%20Use%20of%20Limb%20Compression%20Devices%20for%20Venous%20Thromboembolism%20Prophylaxis%20prn.pdf) | |[718](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/718%20Powered%20Exoskeleton%20for%20Ambulation%20in%20Patients%20with%20Lower%20Limb%20Disabilities%20prn.pdf) | |[Powered Exoskeleton with Lower Limb Disabilities](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/718%20Powered%20Exoskeleton%20for%20Ambulation%20in%20Patients%20with%20Lower%20Limb%20Disabilities%20prn.pdf) | |[047](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/047%20Preauthorization%20Request%20Form%20for%20379%20Surgical%20Management%20of%20Obesity%20Policy%20prn.pdf) | |[Preauthorization Request Form for 379 Surgical Management of Obesity Policy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/047%20Preauthorization%20Request%20Form%20for%20379%20Surgical%20Management%20of%20Obesity%20Policy%20prn.pdf) | |[926](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/926%20Preauthorization%20Request%20Form%20for%20Gene%20Therapy%20for%20Inherited%20Retinal%20Dystrophy%20prn.pdf) | |[Preauthorization Request Form for Gene Therapy for Inherited Retinal Dystrophy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/926%20Preauthorization%20Request%20Form%20for%20Gene%20Therapy%20for%20Inherited%20Retinal%20Dystrophy%20prn.pdf) | |[057](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/057%20Pregabalin%20%28Lyrica%20and%20Lyrica%20CR%29%20prn.pdf) | |[Pregabalin Screening | |[Prior Authorization Request Form for Zulresso (Brexanolone) for the Treatment of Postpartum Depression MP 147](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/148%20Prior%20Authorization%20Request%20%20Form%20for%20Zulresso%20%28Brexanalone%29%20for%20the%20Treatment%20of%20Postpartum%20Depression%20prn.pdf) | |[193](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/193%20Prior%20Authorization%20Request%20Form%20for%20Adstiladrin%20%28nadofaragene%20firadenovec-vncg%29.pdf) | |[Prior Authorization for Adstiladrin (nadofaragene firadenovec-vncg)](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/193%20Prior%20Authorization%20Request%20Form%20for%20Adstiladrin%20%28nadofaragene%20firadenovec-vncg%29.pdf) | |[694](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/694%20Assisted%20Reproductive%20Technology%20Services%20Form%20for%20Policy%20Infertility%20Diagnosis%20and%20Treatment%20prn.pdf) | |[Prior Authorization Request Form for Assisted Reproductive Services](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/694%20Assisted%20Reproductive%20Technology%20Services%20Form%20for%20Policy%20Infertility%20Diagnosis%20and%20Treatment%20prn.pdf) | |[942](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/943%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20%20Multiple%20Myeloma%20%20ABECMA%20%28Idecabtagene%20Vicleucel%29.pdf) | |[Prior Authorization Request Form for CAR T-Cell Therapy Services for Multiple Myeloma ABECMA (Idecabtagene Vicleucel)](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/943%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20%20Multiple%20Myeloma%20%20ABECMA%20%28Idecabtagene%20Vicleucel%29.pdf) | |[945](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/945%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20B-cell%20Acute%20Lymphoblastic%20Leukemia%20%28Brexucabtagene%20Autoleucel%29.pdf) | |[Prior Authorization Request for CAR T-Cell Therapy Services for B-cell Acute Lymphoblastic Leukemia (Brexucabtagene Autoleucel)](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/945%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20B-cell%20Acute%20Lymphoblastic%20Leukemia%20%28Brexucabtagene%20Autoleucel%29.pdf) | |[925](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/925%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20B-cell%20Acute%20Lymphoblastic%20Leukemia%20%28tisagenlecleucel%29%20MP%20066%20prn.pdf) | |[Prior Authorization Request Form for CAR T-Cell Therapy Services for B-cell Acute Lymphoblastic Leukemia (tisagenlecleucel) MP 066](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/925%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20B-cell%20Acute%20Lymphoblastic%20Leukemia%20%28tisagenlecleucel%29%20MP%20066%20prn.pdf) | |[944](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/944%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20Follicular%20Lymphoma%20%28Axicabtagene%20Ciloleucel%29.pdf) | |[Prior Authorization Request Form CAR Therapy for Follicular Lymphoma (Axicabtagene Ciloleucel)](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/944%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20Follicular%20Lymphoma%20%28Axicabtagene%20Ciloleucel%29.pdf) | |[940](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/940%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20Mantle%20Cell%20Lymphoma%20%28Brexucabtagene%20Autoleucel%29%20MP%20066.pdf) | |[Prior Authorization Request Form for CAR T-Cell Therapy Services for Mantle Cell Lymphoma (Brexucabtagene Autoleucel) MP 066](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/940%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20Mantle%20Cell%20Lymphoma%20%28Brexucabtagene%20Autoleucel%29%20MP%20066.pdf) | |[941](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/941%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20Non-Hodgkin%20Lymphoma%20%28Lisocabtagene%20Maraleucel%29.pdf) | |[Prior Authorization CAR Therapy for Non-Hodgkin Lymphoma (Lisocabtagene Maraleucel)](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/941%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20Non-Hodgkin%20Lymphoma%20%28Lisocabtagene%20Maraleucel%29.pdf) | |[924](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/924%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20Treatment%20of%20Diffuse%20Large%20B-cell%20Lymphoma%20prn.pdf) | |[Prior Authorization Request Form for CAR T-Cell Therapy Services for Treatment of Diffuse Large B-cell Lymphoma](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/924%20Prior%20Authorization%20Request%20Form%20for%20CAR%20T-Cell%20Therapy%20Services%20for%20Treatment%20of%20Diffuse%20Large%20B-cell%20Lymphoma%20prn.pdf) | |[845](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/845%20Prior%20Authorization%20Request%20Form%20for%20Continuous%20or%20Intermittent%20Monitoring%20of%20Glucose%20in%20Interstitial%20Fluid%20and%20Artificial%20Pancreas%20Device%20Systems%20prn.pdf) | |[Prior Authorization Request Form for Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid and Artificial Pancreas Device Systems](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/845%20Prior%20Authorization%20Request%20Form%20for%20Continuous%20or%20Intermittent%20Monitoring%20of%20Glucose%20in%20Interstitial%20Fluid%20and%20Artificial%20Pancreas%20Device%20Systems%20prn.pdf) | |[927](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/927%20Prior%20Authorization%20Request%20Form%20for%20Diagnosis%20and%20Treatment%20of%20Sacroiliac%20Joint%20Pain%20MP%20320.pdf) | |[Prior Authorization Request Form for Diagnosis and Treatment of Sacroiliac Joint Pain MP 320](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/927%20Prior%20Authorization%20Request%20Form%20for%20Diagnosis%20and%20Treatment%20of%20Sacroiliac%20Joint%20Pain%20MP%20320.pdf) | |[025](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/025%20Prior%20Authorization%20Request%20Form%20for%20Duchenne%20Muscular%20Dystrophy.pdf) | |[Prior Authorization Request Form for Duchenne Muscular Dystrophy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/025%20Prior%20Authorization%20Request%20Form%20for%20Duchenne%20Muscular%20Dystrophy.pdf) | |[902](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/902%20Prior%20Authorization%20Request%20Form%20for%20Electrolysis%20for%20Gender%20Affirming%20Services%20MP%20189%20prn.pdf) | |[Prior Authorization Request Form for Electrolysis for Gender Affirming Services MP 189](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/902%20Prior%20Authorization%20Request%20Form%20for%20Electrolysis%20for%20Gender%20Affirming%20Services%20MP%20189%20prn.pdf) | |[094](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/094%20Prior%20Authorization%20Request%20Form%20for%20Esketamine%20Nasal%20Spray%20and%20Intravenous%20Ketamine%20for%20Mental%20Health%20Conditions.pdf) | |[Prior Authorization Request Form for Esketamine Nasal Spray and Intravenous Ketamine for Mental Health Conditions](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/094%20Prior%20Authorization%20Request%20Form%20for%20Esketamine%20Nasal%20Spray%20and%20Intravenous%20Ketamine%20for%20Mental%20Health%20Conditions.pdf) | |[901](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/901%20Prior%20Authorization%20Request%20%20Form%20for%20Gender%20Affirming%20Services%20%28Transgender%20Services%29%20MP%20189%20prn.pdf) | |[Prior Authorization Request Form for Gender Affirming Services (Transgender Services) MP 189](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/901%20Prior%20Authorization%20Request%20%20Form%20for%20Gender%20Affirming%20Services%20%28Transgender%20Services%29%20MP%20189%20prn.pdf) | |[169](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/169%20Prior%20Authorization%20Request%20Form%20for%20Gene%20Therapies%20for%20Hemophilia%20B.pdf) | |[Prior Authorization Request Form for Gene Therapies for Hemophilia B](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/169%20Prior%20Authorization%20Request%20Form%20for%20Gene%20Therapies%20for%20Hemophilia%20B.pdf) | |[216](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/216%20Prior%20Authorization%20Request%20Form%20for%20Gene%20Therapies%20for%20Thalassemia%20Zynteglo%20Betibeglogene%20automeucel%20MP%20215.pdf) | |[Prior Authorization Request Form for Gene Therapies for Thalassemia Zynteglo Betibeglogene automeucel](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/216%20Prior%20Authorization%20Request%20Form%20for%20Gene%20Therapies%20for%20Thalassemia%20Zynteglo%20Betibeglogene%20automeucel%20MP%20215.pdf) | |[242](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/242%20Prior%20Authorization%20Request%20Form%20for%20Gene%20Therapy%20for%20Cerebral%20Adrenoleukodystrophy%20SKYSONA.pdf) | |[Prior Authorization Request Form for Gene Therapy for Cerebral Adrenoleukodystrophy SKYSONA](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/242%20Prior%20Authorization%20Request%20Form%20for%20Gene%20Therapy%20for%20Cerebral%20Adrenoleukodystrophy%20SKYSONA.pdf) | |[973](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/973%20Prior%20Authorization%20Request%20Form%20for%20Myoelectric%20Prosthetic%20and%20Components%20for%20the%20Upper%20Limb%20MP%20227.pdf) | |[Prior Authorization Request Form for Myoelectric Prosthetic and Components for the Upper Limb MP 227](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/973%20Prior%20Authorization%20Request%20Form%20for%20Myoelectric%20Prosthetic%20and%20Components%20for%20the%20Upper%20Limb%20MP%20227.pdf) | |[160](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/160%20Prior%20Authorization%20Request%20Form%20for%20Scenesse%20MP%20077.pdf) | |[Prior Authorization Request Form for Scenesse MP 077](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/160%20Prior%20Authorization%20Request%20Form%20for%20Scenesse%20MP%20077.pdf) | |[956](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/956%20Prior%20Authorization%20Request%20Form%20for%20Surgical%20and%20Transesophageal%20Endoscopic%20Procedures%20to%20Treat%20Gastroesophageal%20Reflux%20Disease%20MP%20920%20prn.pdf) | |[Prior Authorization Request Form for Surgical and Transesophageal Endoscopic Procedures to Treat Gastroesophageal Reflux Disease MP 920](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/956%20Prior%20Authorization%20Request%20Form%20for%20Surgical%20and%20Transesophageal%20Endoscopic%20Procedures%20to%20Treat%20Gastroesophageal%20Reflux%20Disease%20MP%20920%20prn.pdf) | |[085](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/085%20Prior%20Authorization%20Request%20Form%20for%20Zolgensma%20%28onasemnogene%20abeparvovec-xioi%29%20for%20Spinal%20Muscular%20Atrophy%20MP%20008%20prn.pdf) | |[Prior Authorization Request Form for Zolgensma abeparvovec-xioi) Spinal Muscular Atrophy MP 008](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/085%20Prior%20Authorization%20Request%20Form%20for%20Zolgensma%20%28onasemnogene%20abeparvovec-xioi%29%20for%20Spinal%20Muscular%20Atrophy%20MP%20008%20prn.pdf) | |[652](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/652%20Progenitor%20Cell%20Therapy%20for%20the%20Treatment%20of%20Damaged%20Myocardium%20Due%20to%20Ischemia%20prn.pdf) | |[Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/652%20Progenitor%20Cell%20Therapy%20for%20the%20Treatment%20of%20Damaged%20Myocardium%20Due%20to%20Ischemia%20prn.pdf) | |[183](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/183%20Prolotherapy%20prn.pdf) | |[Prolotherapy](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/183%20Prolotherapy%20prn.pdf) | |[709](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/709%20Proteomic%20Testing%20for%20Systemic%20Therapy%20in%20Non-Small-Cell%20Lung%20Cancer%20prn.pdf) | |[Proteomic Testing for Systemic Therapy in Non-Small-Cell Lung Cancer](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/709%20Proteomic%20Testing%20for%20Systemic%20Therapy%20in%20Non-Small-Cell%20Lung%20Cancer%20prn.pdf) | |[030](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/030%20Proton%20Pump%20Inhibitors%20prn.pdf) | |[Proton Pump Inhibitors](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/030%20Proton%20Pump%20Inhibitors%20prn.pdf) | | Care Cancer Program (Radiation Oncology)](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/937%20Quality%20Care%20Cancer%20Program%20%28Radiation%20Oncology%29.pdf) | |[938](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/938%20Quality%20Care%20Cancer%20Program%20%28Radiation%20Oncology%29%20CPT%20and%20HCPCS%20Codes.pdf) | |[Quality Care Cancer Program Codes](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/938%20Quality%20Care%20Cancer%20Program%20%28Radiation%20Oncology%29%20CPT%20and%20HCPCS%20Codes.pdf) | |[554](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/554%20Quantitative%20Electroencephalography%20as%20a%20Diagnostic%20Aid%20for%20Attention-Deficit%20Hyperactivity%20Disorder%20prn.pdf) | |[Quantitative |[Radioembolization for Primary and Tumors of the Liver](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/292%20Radioembolization%20for%20Primary%20and%20Metastatic%20Tumors%20of%20the%20Liver%20prn.pdf) | |[259](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/259%20Radiofrequency%20Ablation%20of%20Miscellaneous%20Solid%20Tumors%20Excluding%20Liver%20Tumors%20prn.pdf) | |[Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/259%20Radiofrequency%20Ablation%20of%20Miscellaneous%20Solid%20Tumors%20Excluding%20Liver%20Tumors%20prn.pdf) | |[794](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/794%20Radiofrequency%20Ablation%20of%20Peripheral%20Nerves%20to%20Treat%20Pain%20prn.pdf) | |[Radiofrequency Ablation of Peripheral Nerves to Treat Pain](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/794%20Radiofrequency%20Ablation%20of%20Peripheral%20Nerves%20to%20Treat%20Pain%20prn.pdf) | |[286](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/286%20Radiofrequency%20Ablation%20of%20Primary%20or%20Metastatic%20Liver%20Tumors%20prn.pdf) | |[Radiofrequency Ablation of Tumors](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/286%20Radiofrequency%20Ablation%20of%20Primary%20or%20Metastatic%20Liver%20Tumors%20prn.pdf) | |[919](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/919%20Radiofrequency%20Ablation%20of%20the%20Renal%20Sympathetic%20Nerves%20as%20a%20Treatment%20for%20Resistant%20Hypertension%20prn.pdf) | |[Radiofrequency Ablation of the Renal Sympathetic Nerves as a Treatment for Resistant Hypertension](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/919%20Radiofrequency%20Ablation%20of%20the%20Renal%20Sympathetic%20Nerves%20as%20a%20Treatment%20for%20Resistant%20Hypertension%20prn.pdf) | |[080](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/080%20Radiofrequency%20Coblation%20Tenotomy%20for%20Musculoskeletal%20Conditions%20prn.pdf) | | and Acoustic or Optical Rhinometry](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/586%20Rhinomanometry%20and%20Acoustic%20or%20Optical%20Rhinometry%20prn.pdf) | |[385](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/385%20Routine%20Foot%20Care%20and%20Debridement%20of%20Toenails%20prn.pdf) | |[Routine Foot Care and |[307](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/307%20Saturation%20Biopsy%20for%20Diagnosis%20and%20Staging%20of%20Prostate%20Cancer%20prn.pdf) |[Saturation Biopsy for Diagnosis Staging of Prostate Cancer](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/307%20Saturation%20Biopsy%20for%20Diagnosis%20and%20Staging%20of%20Prostate%20Cancer%20prn.pdf) | |[077](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/077%20Scenesse%20afamelanotide%20for%20the%20treatment%20of%20Erythropoietic%20protoporphyria%20prn.pdf) | |[Scenesse afamelanotide for protoporphyria](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/077%20Scenesse%20afamelanotide%20for%20the%20treatment%20of%20Erythropoietic%20protoporphyria%20prn.pdf) | |[494](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/494%20Scintimammography%2C%20Breast-Specific%20Gamma%20Imaging%2C%20and%20Molecular%20Breast%20Imaging%20prn.pdf) | |[Scintimammography, Breast-Specific Gamma Imaging, and Breast Imaging](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/494%20Scintimammography%2C%20Breast-Specific%20Gamma%20Imaging%2C%20and%20Molecular%20Breast%20Imaging%20prn.pdf) | |[480](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/480%20Semi-Implantable%20and%20Fully%20Implantable%20Middle%20Ear%20Hearing%20Aid%20prn.pdf) | |[Semi-Implantable and Fully Implantable Middle Ear Aid](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/480%20Semi-Implantable%20and%20Fully%20Implantable%20Middle%20Ear%20Hearing%20Aid%20prn.pdf) |[659](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/659%20Sensory%20Integration%20Therapy%20prn.pdf) | |[Sensory Celiac Disease](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/138%20Serological%20Diagnosis%20of%20Celiac%20Disease%20prn.pdf) | |[551](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/551%20Serum%20Antibodies%20for%20the%20Diagnosis%20of%20Inflammatory%20Bowel%20Disease%20prn.pdf) | |[Serum Antibodies for the Diagnosis of Inflammatory Bowel Disease](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/551%20Serum%20Antibodies%20for%20the%20Diagnosis%20of%20Inflammatory%20Bowel%20Disease%20prn.pdf) | |[290](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/290%20Serum%20Biomarker%20Human%20Epididymis%20Protein%204%20-%20HE4%20prn.pdf) | |[Serum Biomarker Human HE4](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/290%20Serum%20Biomarker%20Human%20Epididymis%20Protein%204%20-%20HE4%20prn.pdf) |[Serum Biomarker Panel Testing for Other Connective Tissue Diseases](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/702%20Serum%20Biomarker%20Panel%20Testing%20for%20Systemic%20Lupus%20Erythematosus%20and%20Other%20Connective%20Tissue%20Diseases%20prn.pdf) | |[538](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/538%20Serum%20Tumor%20Markers%20for%20Breast%20and%20Gastrointestinal%20Malignancies%20prn.pdf) | Tumor Markers for Breast and Gastrointestinal Malignancies](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/538%20Serum%20Tumor%20Markers%20for%20Breast%20and%20Gastrointestinal%20Malignancies%20prn.pdf) | |[078](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/078%20Sexual%20Dysfunction%20Diagnosis%20and%20Therapy%20prn.pdf) | |[Sexual Dysfunction (SMA) Arthroereisis](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/299%20Subtalar%20Arthroereisis%20prn.pdf) | |[105](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/105%20Supportive%20Care%20Treatments%20for%20Patients%20with%20Cancer.pdf) | |[Supportive Treatments for Patients Cancer](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/105%20Supportive%20Care%20Treatments%20for%20Patients%20with%20Cancer.pdf) | |[609](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/609%20Suprachoroidal%20Delivery%20of%20Pharmacologic%20Agents%20prn.pdf) | |[Suprachoroidal Delivery of for Gastroesophageal Reflux Disease](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/920%20Surgical%20and%20Transesophageal%20Endoscopic%20Procedures%20to%20Treat%20Gastroesophageal%20Reflux%20Disease%20prn.pdf) | |[801](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/801%20Surgical%20Deactivation%20of%20Headache%20Trigger%20Sites%20prn.pdf) | |[Surgical Deactivation of Headache Trigger Sites](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/801%20Surgical%20Deactivation%20of%20Headache%20Trigger%20Sites%20prn.pdf) | |[570](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/570%20Surgical%20Interruption%20of%20Pelvic%20Nerve%20Pathways%20for%20Primary%20and%20Secondary%20Dysmenorrhea%20prn.pdf) | |[Surgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/570%20Surgical%20Interruption%20of%20Pelvic%20Nerve%20Pathways%20for%20Primary%20and%20Secondary%20Dysmenorrhea%20prn.pdf) | |[176](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/176%20Surgical%20Left%20Atrial%20Appendage%20Occlusion%20Devices%20for%20Stroke%20Prevention%20in%20Atrial%20Fibrillation.pdf) | |[Surgical Left Atrial Appendage in Atrial Fibrillation](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/176%20Surgical%20Left%20Atrial%20Appendage%20Occlusion%20Devices%20for%20Stroke%20Prevention%20in%20Atrial%20Fibrillation.pdf) | |[130](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/130%20Surgical%20Treatment%20of%20Snoring%20and%20Obstructive%20Sleep%20Apnea%20Syndrome%20prn.pdf) | |[Surgical Treatment of Snoring | |[Surgical | |[342](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/342%20Thermography%20prn.pdf) | |[Thermography](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/342%20Thermography%20prn.pdf) | | is Test with new metadata label](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/upload-group-category-test-asset.png) | |[321](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/321%20Threshold%20Electrical%20Stimulation%20as%20a%20Treatment%20of%20Motor%20Disorders%20prn.pdf) | |[Threshold Electrical Stimulation as a Motor | | | |[Transcatheter Valve Implantation](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/403%20Transcatheter%20Pulmonary%20Valve%20Implantation%20prn.pdf) | |[297](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/297%20Transcranial%20Magnetic%20Stimulation%20as%20a%20Treatment%20of%20Depression%20prn.pdf) | |[Transcranial Magnetic Stimulation as a Treatment of Depression](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/297%20Transcranial%20Magnetic%20Stimulation%20as%20a%20Treatment%20of%20Depression%20prn.pdf) | |[003](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/003%20Transcutaneous%20Electrical%20Nerve%20Stimulation%20prn.pdf) | |[Transcutaneous Electrical Nerve Venous | | Point and Tender Point Injections](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/604%20Trigger%20Point%20and%20Tender%20Point%20Injections%20prn.pdf) | |[167](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/167%20Tumor%20Markers%20for%20diagnosis%20and%20management%20of%20cancer%20prn.pdf) | |[Tumor Markers for diagnosis and management of cancer](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/167%20Tumor%20Markers%20for%20diagnosis%20and%20management%20of%20cancer%20prn.pdf) | |[303](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/303%20Ultrasonographic%20Evaluation%20of%20Skin%20Lesions%20prn.pdf) | |[Ultrasonographic Evaluation of Skin Lesions](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/303%20Ultrasonographic%20Evaluation%20of%20Skin%20Lesions%20prn.pdf) | |[547](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/547%20Ultrasonographic%20Measurement%20of%20Carotid%20Intima-Medial%20Thickness%20as%20an%20Assessment%20of%20Subclinical%20Atherosclerosis%20prn.pdf) | |[Ultrasonographic Measurement of Carotid Intima-Medial Thickness an Assessment of Subclinical Atherosclerosis](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/547%20Ultrasonographic%20Measurement%20of%20Carotid%20Intima-Medial%20Thickness%20as%20an%20Assessment%20of%20Subclinical%20Atherosclerosis%20prn.pdf) | |[497](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/497%20Ultrasound%20Accelerated%20Fracture%20Healing%20Device%20prn.pdf) | |[Ultrasound Accelerated Fracture Healing Device](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/497%20Ultrasound%20Accelerated%20Fracture%20Healing%20Device%20prn.pdf) |[445](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/445%20Ultrasound%20for%20the%20Evaluation%20of%20Paranasal%20Sinuses%20prn.pdf) | |[Ultrasound for Evaluation of Paranasal Sinuses](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/445%20Ultrasound%20for%20the%20Evaluation%20of%20Paranasal%20Sinuses%20prn.pdf) | | Metabolite |[Urological Supplies](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/370%20Urological%20Supplies.pdf) | |[060](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/060%20Uterus%20Transplantation%20for%20Absolute%20Uterine%20Factor%20Infertility.pdf) for Uterine Infertility](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/060%20Uterus%20Transplantation%20for%20Absolute%20Uterine%20Factor%20Infertility.pdf) | | |[Vagus Nerve Stimulation](/medical-policies/sites/g/files/csphws2091/files/acquiadam-assets/474%20Vagus%20Nerve%20Stimulation%20prn.pdf) | Body | | Endoscopy for Gastrointestinal "}